Favourites   Have ideas?  Sign in / Register

Positive:

Negative:


Hematologic and musculoskeletal disorders segment

KROS Keros Therapeutics, Inc. - common stock 7.02% up -1.94% 8.96 + Biopharma, Medicine, Hematologic and musculoskeletal disorders

+ My List


We do not provide financial advice. All displayed data is the result of experiments, and a subjective assessment. All decisions that will be made based on this data are made at your own risk. Thank you for understanding.